Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Marenghi, C"" wg kryterium: Autor


Tytuł:
A0821 - Real world data of active surveillance protocols in low-risk prostate cancer. Intensity of follow-up may be reduced according to a 14 years' experience.
Autorzy:
Marenghi, C. (AUTHOR)
Badenchini, F. (AUTHOR)
Avuzzi, B. (AUTHOR)
Catanzaro, M.A. (AUTHOR)
Claps, M. (AUTHOR)
Casbarra, A. (AUTHOR)
Noris Chiorda, B. (AUTHOR)
Guadalupi, V. (AUTHOR)
Stellato, M. (AUTHOR)
Nazzani, S. (AUTHOR)
Stagn, S. (AUTHOR)
Cattaneo, L. (AUTHOR)
Casale, A. (AUTHOR)
Messina, A. (AUTHOR)
Villa, S. (AUTHOR)
Macchi, A. (AUTHOR)
Torelli, T. (AUTHOR)
Tesone, A. (AUTHOR)
Verzoni, E. (AUTHOR)
Procopio, G. (AUTHOR)
Pokaż więcej
Źródło:
European Urology. 2024 Supplement 1, Vol. 85, pS1830-S1830. 1p.
Czasopismo naukowe
Tytuł:
A0822 - Does multiparametric (mp) MRI and MRI-informed biopsy improve risk allocation of men at inclusion in active surveillance for low-risk prostatic cancer? Results of per-protocol population of the prospective single institution SPRINT trial.
Autorzy:
Marenghi, C. (AUTHOR)
Badenchini, F. (AUTHOR)
Rancati, T. (AUTHOR)
Avuzzi, B. (AUTHOR)
Messina, A. (AUTHOR)
Casale, A. (AUTHOR)
Catanzaro, M.A. (AUTHOR)
Claps, M. (AUTHOR)
Casbarra, A. (AUTHOR)
Noris Chiorda, B. (AUTHOR)
Guadalupi, V. (AUTHOR)
Stellato, M. (AUTHOR)
Nazzani, S. (AUTHOR)
Stagni, S. (AUTHOR)
Cattaneo, L. (AUTHOR)
Macchi, A. (AUTHOR)
Villa, S. (AUTHOR)
Torelli, T. (AUTHOR)
Verzoni, E. (AUTHOR)
Tesone, A. (AUTHOR)
Pokaż więcej
Źródło:
European Urology. 2024 Supplement 1, Vol. 85, pS1831-S1831. 1p.
Czasopismo naukowe
Tytuł:
P051 - Grade reclassification during active surveillance in low risk prostate cancer men selected with an MRI-informed biopsy
Autorzy:
Marenghi, C.
Badenchini, F.
Avuzzi, B.
Catanzaro, M.A.
Claps, M.
Casbarra, A.
Noris Chiorda, B.
Guadalupi, V.
Stellato, M.
Nazzani, S.
Stagni, S.
Cattaneo, L.
Casale, A.
Messina, A.
Villa, S.
Macchi, A.
Torelli, T.
Verzoni, E.
Procopio, G.
Rancati, T.
Nicolai, N.
Pokaż więcej
Źródło:
In European Urology Open Science November 2023 57 Supplement 1:S79-S79
Czasopismo naukowe
Tytuł:
Potential of the Stromal Matricellular Protein Periostin as a Biomarker to Improve Risk Assessment in Prostate Cancer.
Autorzy:
Doldi V; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Lecchi M; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Ljevar S; Clinical Epidemiology and Trial Organization, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Colecchia M; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Campi E; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Centonze G; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Marenghi C; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Rancati T; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Miceli R; Clinical Epidemiology and Trial Organization, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Verderio P; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Valdagni R; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.; Division of Radiation Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20133 Milan, Italy.
Gandellini P; Department of Biosciences, University of Milan, 20133 Milan, Italy.
Zaffaroni N; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jul 20; Vol. 23 (14). Date of Electronic Publication: 2022 Jul 20.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/metabolism
Soft Tissue Neoplasms*
Biomarkers ; Biomarkers, Tumor/metabolism ; Humans ; Immunohistochemistry ; Male ; Prostatectomy ; Risk Assessment
Czasopismo naukowe
Tytuł:
PO-1595 Automated stability study on mpMRI prostate radiomics features to variations in segmentation.
Autorzy:
Thulasi Seetha, S. (AUTHOR)
Garanzini, E. (AUTHOR)
Messina, A. (AUTHOR)
Tenconi, C. (AUTHOR)
Marenghi, C. (AUTHOR)
Avuzzi, B. (AUTHOR)
Catanzaro, M. (AUTHOR)
Stagni, S. (AUTHOR)
Villa, S. (AUTHOR)
Noris Chiorda, B. (AUTHOR)
Badenchini, F. (AUTHOR)
Panchakumar, J. (AUTHOR)
Bertocchi, E. (AUTHOR)
Pignoli, E. (AUTHOR)
Valdagni, R. (AUTHOR)
Casale, A. (AUTHOR)
Nicolai, N. (AUTHOR)
Rancati, T. (AUTHOR)
Pokaż więcej
Źródło:
Radiotherapy & Oncology. 2022 Supplement 1, Vol. 170, pS1377-S1379. 3p.
Czasopismo naukowe
Tytuł:
Prediction of Grade Reclassification of Prostate Cancer Patients on Active Surveillance through the Combination of a Three-miRNA Signature and Selected Clinical Variables.
Autorzy:
Gandellini P; Department of Biosciences, University of Milan, 20133 Milan, Italy.
Ciniselli CM; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Rancati T; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Marenghi C; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Doldi V; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
El Bezawy R; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Lecchi M; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Claps M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Catanzaro M; Division of Urology, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Avuzzi B; Division of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Campi E; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Colecchia M; Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Badenchini F; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Verderio P; Bioinformatics and Biostatistics Unit, Department of Applied Research and Technological Development, Fondazione IRCSS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Valdagni R; Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.; Division of Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, 20133 Milan, Italy.
Zaffaroni N; Molecular Pharmacology Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 May 18; Vol. 13 (10). Date of Electronic Publication: 2021 May 18.
Typ publikacji:
Journal Article
Czasopismo naukowe
Tytuł:
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study.
Autorzy:
Rocco B; Urology Unit, University of Modena and Reggio Emilia, Modena, Italy.
Sighinolfi MC; Urology Unit, University of Modena and Reggio Emilia, Modena, italy.
Sandri M; Data Methods and Systems Statistical Laboratory, University of Brescia, Brescia, Italy.
Altieri V; Urology Unito, Humanitas Gavazzeni, Bergamo, Italy.
Amenta M; Urology Unit, Azienda ULSS n.4 Veneto Orientale, Portogruaro, Italy.
Annino F; Urology Unit, Ospedale San Donato, Arezzo, Italy.
Antonelli A; Urology Unit, Ospedale Maggiore Borgo Trento, Verona, Italy.
Baio R; Urology Unit, AOU San Giovanni di Dio e Ruggi D'Aragona, Salerno, Italy.
Bertolo R; Urology Unit, Ospedale San Carlo di Nancy, Roma, Italy.
Bocciardi A; Urology Unit, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Borghesi M; Urology Unit, Ospedale San Martino, Genova, Italy.
Bove P; Urology Unit, Ospedale San Carlo di Nancy, Roma, Italy.
Bozzini G; Urology Unit, ASST Valle Olona, Busto Arsizio, Italy.
Brunocilla E; AOU Policlinico Sant'Orsola Malpighi, Bologna, Italy.
Cacciamani G; Catherine and Joseph Aresty Department of Urology, USC Institute of Urology, Los Angeles, CA, USA.
Calori A; Urology Unit, ASST Valle Olona, Busto Arsizio, Italy.
Cafarelli A; Urology Unit, Villa Igea, Ancona, Italy.
Celia A; Urology Unit, Ospedale San Bassiano, Bassano del Grappa, Italy.
Carbone A; Urology Unit, Sapienza University, Roma, Italy.
Cocci A; Urology Unit, Azienda Ospedaliero Universitaria Careggi Firenze, Italy.
Corsaro A; Urology Unit, AULSS 4, Portogruaro, Italy.
Costa G; Urology Unit, Ospedale San Bassiano, Bassano del Grappa, Italy.
Ceruti C; Urology Unit, AOU Citta della Salute e della Scienza, Torino, Italy.
Cindolo L; Urology Unit, Villa Stuart, Roma, Italy.
Crivellaro S; Urology Unit, Azienda Ospedaliero-Universitaria di Udine, Italy.
Dalpiaz O; Urology Unit, Medical University of Graz, Graz, Austria.
D'Agostino D; Urology Unit, Policlinico Abano Terme, Abano Terme, Italy.
Dall'Oglio B; Urology Unit, ASST Mantova, Italy.
Dente D; Abano Terme Hospital, Padua, Italy.
Falabella R; Urology Unit, San Carlo di Potenza, Potenza, Italy.
Falsaperla M; Urology Unit, ARNAS Garibaldi Hospital, Catania, Italy.
Ferrari G; Hesperia Hospital, Modena, Italy.
Finocchiaro M; Urology Unit, ARNAS Garibaldi Hospital, Catania, Italy.
Flammia S; Urology Unit, Policlinico Umberto I, Rome, Italy.
Gaboardi F; Urology Unit, San Raffaele Turro, Milan, Italy.
Galfano A; Endourology Sub-Unit, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
Gallo F; Urology Unit, Ospedale San Paolo di Savona, Savona, Italy.
Gatti L; Hesperia Hospital, Modena, Italy.
Greco F; Urology Unito, Humanitas Gavazzeni, Bergamo, Italy.
Khorrami S; Ospedale San Donato, Arezzo, Italy.
Leonardo C; Urology Unit, Policlinico Umberto I, Rome, Italy.
Marenghi C; ASAT Rhodense Ospedale Guido Salvini di Garbagnate, Garbagnate, Italy.
Nucciotti R; Urology Unit, Azienda USL Toscana, Grosseto, Italy.
Oderda M; Urology Unit, Città della Salute e della Scienza Hospital, Torino, Italy.
Pagliarulo V; Urology Unit, Ospedale Vito Fazzi, Lecce, Italy.
Parma P; Urology Unit, Ospedale San Carlo Poma, Mantova, Italy.
Pastore AL; Urology Unit, Sapienza University, Rome, Italy.
Pini G; Urology Unit, San Raffaele Turro, Milan, Italy.
Porreca A; Urology Unit, Policlinico Abano Terme, Abano, Padova, Italy.
Pucci L; Urology Unit, Azienda Ospedaliera A. Cardarelli, Naples, Italy.
Schenone M; Urology Unit, Ospedale San Paolo, Savona, Italy.
Schiavina R; Urology Unit, AOU Policlinico Sant'Orsola Malpighi, Bologna, Italy.
Sciorio C; Urology Unit, ASST Ospedale Manzoni, Lecco, Italy.
Spirito L; Urology Unit, ASST Manzoni, Lecco, Italy.
Tafuri A; Urology Unit, Azienda Ospedaliera Universitaria Integrata di Verona - Ospedale Maggiore Borgo Trento, Verona, Italy.
Terrone C; Urology, Ospedale IRRCS Policlinico San Martino Genova, Italy.
Umari P; Urology Unit, Maggiore della Carità Hospital, Novara, Italy.
Varca V; Urology Unit, ASAT Rhodense Ospedale Guido Salvini di Garbagnate, Garbagnate, Italy.
Veneziano D; Urology Unit, AO Bianchi Melacrino Morelli, Calabria, Italy.
Verze P; Urology Unit, AOU San Giovanni di Rio e Ruggi d'Aragona, Salerno, Italy.
Volpe A; Urology, Urology Unit, Ospedale Maggiore della Carita, Novara, Italy.
Micali S; Urology Unit, University of Modena and Reggio Emilia, Modena, Italy.
Berti L; University of Modena and Reggio Emilia, Modena, Italy.
Zaramella S; Urology Unit, Ospedale degli Infermi, Biella, Italy.
Zegna L; Ospedale degli infermi, Biella, Italy.
Bertellini E; Department of Anesthesiology, Azienda Ospedaliero-Universitaria of Modena, Modena, Italy.
Minervini A; Azienda Ospedaliero Universitaria Careggi, Firenze, Italy.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Jan; Vol. 127 (1), pp. 56-63. Date of Electronic Publication: 2020 Oct 19.
Typ publikacji:
Journal Article; Multicenter Study; Observational Study
MeSH Terms:
Pandemics*
SARS-CoV-2*
COVID-19/*epidemiology
Urologic Diseases/*surgery
Urologic Surgical Procedures/*statistics & numerical data
Comorbidity ; Elective Surgical Procedures ; Humans ; Italy/epidemiology ; Surveys and Questionnaires ; Urologic Diseases/epidemiology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies